Product Information
MIRTAZAPINE 7.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.3486 per EA under NDC 57237000705. Its NADAC has been published 652 times since Apr 9, 2014.
FDA first approved this application on Oct 22, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237000705
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIRTAZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA076921FDA Approved
10/22/2004
TE Code
AB
On Market Since
10/22/2004
Price Statistics
The NADAC for MIRTAZAPINE 7.5 MG TABLET has been published 652 times since Apr 9, 2014, and over the history we have for it it has risen 47.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3486 per EA |
|---|---|
| All-time high | $1.8432 (Feb 10, 2016) |
| All-time low | $0.2371 (Apr 9, 2014) |
| 52-week high | $0.3881 |
| 52-week low | $0.3486 |
| Median price | $0.8833 |
| Average price | $0.9669 |
| Largest weekly change | +390.3% (Apr 23, 2014) |
| Weeks tracked | 652 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mirtazapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIRTAZAPINE 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 7.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.3486 per EA (NDC 57237000705), effective Sep 30, 2026.
How has the price of MIRTAZAPINE 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIRTAZAPINE 7.5 MG TABLET has risen 47.0%. It has been tracked across 652 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 7.5 MG TABLET?
Since Apr 9, 2014, the NADAC for MIRTAZAPINE 7.5 MG TABLET has ranged from a low of $0.2371 (Apr 9, 2014) to a high of $1.8432 (Feb 10, 2016), with a median of $0.8833 per EA.
Are there cheaper alternatives to MIRTAZAPINE 7.5 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIRTAZAPINE 7.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MIRTAZAPINE 7.5 MG TABLET?
MIRTAZAPINE 7.5 MG TABLET (NDC 57237000705) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.